Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Bay Area's PellePharm Wins FDA Breakthrough Tag for Genetic Rare Disease Drug November 19, 2017 Chugai Commits $220M Into Singapore Drug Lab December 28, 2017 Celldex Announces Additions To The Board Of Directors And Senior Management Team June 15, 2017